RBC Capital analyst Michael Carroll raised the firm's price target on CareTrust REIT to $44 from $41 and keeps an Outperform rating on the shares after its Q4 results. The company remains well positioned to be aggressive deploying capital accretively via its three operating platforms, though the firm is also cutting its FY26 FFO per share by 8c to $2.01 to reflect investment timing adjustments and higher G&A expenses, the analyst tells investors in a research note.
